Nanoviricides Inc (NNVC)
1.315
+0.04
(+2.73%)
USD |
NYAM |
Nov 22, 12:23
Nanoviricides Total Assets (Quarterly): 11.74M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.74M |
| June 30, 2024 | 12.82M |
| March 31, 2024 | 11.46M |
| December 31, 2023 | 13.40M |
| September 30, 2023 | 15.42M |
| June 30, 2023 | 16.90M |
| March 31, 2023 | 18.58M |
| December 31, 2022 | 20.34M |
| September 30, 2022 | 22.08M |
| June 30, 2022 | 23.49M |
| March 31, 2022 | 25.14M |
| December 31, 2021 | 26.81M |
| September 30, 2021 | 29.18M |
| June 30, 2021 | 30.26M |
| March 31, 2021 | 32.76M |
| December 31, 2020 | 28.09M |
| September 30, 2020 | 31.85M |
| June 30, 2020 | 23.91M |
| March 31, 2020 | 16.53M |
| December 31, 2019 | 11.62M |
| September 30, 2019 | 11.79M |
| June 30, 2019 | 13.45M |
| March 31, 2019 | 15.39M |
| December 31, 2018 | 15.00M |
| September 30, 2018 | 17.37M |
| Date | Value |
|---|---|
| June 30, 2018 | 18.55M |
| March 31, 2018 | 22.34M |
| December 31, 2017 | 23.73M |
| September 30, 2017 | 25.27M |
| June 30, 2017 | 27.00M |
| March 31, 2017 | 28.58M |
| December 31, 2016 | 31.36M |
| September 30, 2016 | 34.22M |
| June 30, 2016 | 36.63M |
| March 31, 2016 | 38.32M |
| December 31, 2015 | 40.85M |
| September 30, 2015 | 42.30M |
| June 30, 2015 | 44.19M |
| March 31, 2015 | 45.60M |
| December 31, 2014 | 47.60M |
| September 30, 2014 | 49.02M |
| June 30, 2014 | 43.86M |
| March 31, 2014 | 40.95M |
| December 31, 2013 | 22.89M |
| September 30, 2013 | 25.11M |
| June 30, 2013 | 16.41M |
| March 31, 2013 | 17.88M |
| December 31, 2012 | 15.61M |
| September 30, 2012 | 14.35M |
| June 30, 2012 | 15.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.46M
Minimum
Mar 2024
32.76M
Maximum
Mar 2021
21.12M
Average
21.21M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
| Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.633M |
| Shareholders Equity (Quarterly) | 10.11M |